VRAX icon

Virax Biolabs

7 hedge funds and large institutions have $141K invested in Virax Biolabs in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$85.3K +$39.1K +17,385 +85%
XT
2
XTX Topco
Cayman Islands
$26.7K +$26.7K +11,863 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$23K +$23K +10,400 New
RS
4
R Squared
Hong Kong
$6.08K +$6.08K +2,700 New
Morgan Stanley
5
Morgan Stanley
New York
$225 +$225 +100 New
Northwestern Mutual Wealth Management
6
Northwestern Mutual Wealth Management
Wisconsin
$45 +$45 +20 New
TRCT
7
Tower Research Capital (TRC)
New York
$20 +$20 +9 New
Renaissance Technologies
8
Renaissance Technologies
New York
-$282K -145,400 Closed
Squarepoint
9
Squarepoint
New York
-$78.8K -40,620 Closed
Jane Street
10
Jane Street
New York
-$22.6K -11,635 Closed
HT
11
Headlands Technologies
Illinois
-$359 -185 Closed